AVITA Medical, Inc. (RCEL) Income towards Parent Company (2018 - 2026)

AVITA Medical (RCEL) has reported Income towards Parent Company for 9 consecutive years, with -$7.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Income towards Parent Company rose 22.75% year-over-year to -$7.7 million; the trailing twelve-month figure through Jun 2026 stood at -$32.2 million (up 16.51% YoY), and the FY2025 full-year result was -$38.4 million, up 21.39% from the prior year.
• Income towards Parent Company declined to -$7.7 million in Q2 2026 per RCEL's latest filing, from -$1.4 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $1.4 million in Q4 2024 and bottomed at -$18.7 million in Q1 2024.
• Historically, Income towards Parent Company has averaged -$9.5 million across 5 years, with a median of -$9.3 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Income towards Parent Company jumped 116.08% in 2024, then plunged 197.78% in 2025.
• Over 5 years, Income towards Parent Company stood at -$4.2 million in 2022, then sank by 114.84% to -$9.0 million in 2023, then soared by 116.08% to $1.4 million in 2024, then slumped by 197.78% to -$1.4 million in 2025, then sank by 443.86% to -$7.7 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$7.7 million, -$1.4 million, and -$13.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.